Condition | Count |
---|---|
Healthy | 8078 |
Breast Cancer | 4608 |
Prostate Cancer | 2676 |
Obesity | 2324 |
Asthma | 2321 |
Data in motion
Clinical trials have long been the backbone of medical advancements, providing critical insights into the efficacy and safety of new treatments. In recent years, certain conditions have dominated the landscape of clinical research. Leading the charge is the 'Healthy' category, representing approximately 40% of the top five conditions studied. This is followed by 'Breast Cancer', which accounts for nearly 23%, highlighting the ongoing global efforts to combat this prevalent disease. 'Prostate Cancer' and 'Obesity' make up about 13% and 12% respectively, reflecting the growing concern over lifestyle-related health issues. Lastly, 'Asthma' rounds out the list at 11%, underscoring the persistent need for respiratory health solutions. This data not only sheds light on current research priorities but also emphasizes the importance of addressing both chronic and lifestyle-related conditions in clinical trials.
Total Enrollment in Phase I, II, and III for the Year 2024
Enrollment trend in studies over the years
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Trend of Clinical Trials Over the Last 10 Years
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years
Comparison of Clinical Trials in Canada vs United States Over the Years
Count of Oncology Trials Starting in the Next 3 Months
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Top 10 Recent Clinical Trials by Completion Date